Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Parkinson’s disease

Antidepressant nortriptyline could slow Parkinson’s pathology

The drug could be used as a multi-functional compound to treat comorbid depression in Parkinson’s disease and also slow down the progress of the disease, researchers say.

MRI scan of the brain


Study shows that the antidepressant nortriptyline could become a multi-functional compound to treat Parkinson’s disease 

One potential strategy for treating Parkinson’s disease is to prevent the formation of intracellular inclusions comprised of misfolded alpha-synuclein in the brain.

In a paper in Neurobiology of Disease (online, 12 July 2017), researchers explored the effect of the antidepressant nortriptyline on the formation of alpha-synuclein[1].

They first showed in vitro that the drug is able to bind directly to alpha-synuclein and interfere with its folding, inhibiting formation of toxic forms of the protein. In both in vitro and animal models they then showed that this led to reduced levels of accumulation, aggregation and neurotoxicity of alpha-synuclein.

Noting that nortriptyline is considered effective and safe for treating comorbid depression in Parkinson’s disease, the team suggested it could become a multi-functional compound to treat the disorder.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203867

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • MRI scan of the brain

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.